STAT Announces 2025 Rankings of Biotech's Top Venture Capital Firms

Annual report recognizes VC firms with the best returns driving health care innovation

BOSTON, Aug. 21, 2025 /PRNewswire/ -- Today, STAT, the leading health and medicine media company, released its annual STAT Report ranking biotech's top venture capital firms.

This report, the sixth of its kind, gives an unfettered view into biotech VC firms' investing successes or shortcomings, sharing financial figures that are rarely seen by the public. Firms are analyzed on several investment metrics, including whether they have doubled, tripled, or even quadrupled their investors' money.

No one else produces such a sweeping examination of biotech VC operations. It follows a methodology devised by STAT six years ago.

The 2025 Report highlights firms that have demonstrated exceptional performance, strategic vision, and a commitment to supporting groundbreaking health care innovations. These firms have been instrumental in funding startups and companies that are at the forefront of medical research, biotechnology, and digital health.

The report comes as the biotech industry faces a series of existential questions and the National Institutes of Health and other federal forces have slashed scientists' funding, putting the research that venture capitalists invest in in jeopardy. The rise of Chinese biotechs is also stirring anxiety among U.S. startups, and even some investors.

"This annual report is by far our most popular,'' said Rick Berke, STAT's co-founder and executive editor. "It's a deep look into the closed-off world of biotech venture capital — where billions of dollars are being invested every year — that you don't get anywhere else.''

The rankings in this STAT Report are based on comprehensive data obtained and objectively analyzed by the team, and do not reflect STAT's opinion of any firms.

Download the 2025 Edition: Ranking Biotech's Top Venture Capital Firms for an essential guide to understanding the forces driving success in biotech venture capital and unlocking the secrets behind the performance of top-rated firms. The report is available for $499 for an individual copy or available for an additional fee to license the report for an entire company.

Contact: Boston Globe Media Communications, 617-851-3396, [email protected]

About STAT:

Founded in 2015, STAT is a digital media company that focuses on delivering fast, deep, and tough-minded journalism about the life sciences. STAT takes you inside academic labs, biotech boardrooms, and political backrooms, casting a critical eye on scientific discoveries, scrutinizing corporate strategies, and chronicling the roiling battles for talent, money, and market share. With an award-winning newsroom, STAT provides indispensable insights and exclusive stories on the technologies, personalities, power brokers, and political forces driving massive changes in the life sciences industry — and a revolution in human health.

STAT has twice been named a Pulitzer Prize finalist and has won a number of prestigious journalism prizes, including the George Polk Awards, Victor Cohn Prize for Excellence in Medical Science Reporting, Edward R. Murrow Awards, and SABEW "Best in Business" Awards.

STAT's main newsroom is located in Boston, and it also has reporters in Washington, D.C., New York City, London, Los Angeles, San Francisco, San Diego, Chicago, and Minneapolis.

About Boston Globe Media:
Boston Globe Media Partners, LLC is a locally owned, award-winning media company serving Boston and New England for over 153 years. Its cornerstone is The Boston Globe, a 27-time Pulitzer Prize-winning news source and one of the most successful metro news organizations in the United States. The Globe is headquartered in Boston with regional bureaus in Washington, D.C., Rhode Island, and New Hampshire. The Globe has been successfully growing its direct subscriber base, today boasting the highest total number of subscribers the organization has had since 2008. The Globe hosts events that connect community members to its journalism and provides a range of digital and home-delivered advertising solutions that reach more consumers than any other New England media brand. Boston Globe Media's portfolio includes The Boston Globe, Globe Opinion, Boston.com, STAT, The B-Side, Globe Publishing Services, Globe Events, Studio/B, and Boston magazine.

SOURCE STAT